Sign inJoin waitlistJoin the waitlist

Melina Marmarelis

Physician Lead -Airways Research Program, University of Pennsylvania · University of Pennsylvania Health System

Credentials: · · · · ·

History

University of Pennsylvania · University of Pennsylvania Health System
Present
Perelman School of Medicine at the University of Pennsylvania
Present
University of Pennsylvania Health System
Present

University of Pennsylvania Health System
2016–2018
Internal Medicine
Massachusetts General Hospital
2013–2016
Harvard Medical School
2009–2013

Research

Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients
Science · 2024 · Co-first of 22 authors · 202 citations
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Nature · 2024 · 178 citations
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results…
Journal of Clinical Oncology · 2024 · 138 citations

Charu Aggarwal
44 papers
Corey Langer
38 papers
RC
Roger Cohen
31 papers
Aditi Singh
28 papers · 6 as a fellow
LS
Lova Sun
28 papers · 2 as a fellow
Christine Ciunci
17 papers
Joshua Bauml
14 papers
CD
Christopher D'Avella
10 papers
Keith Cengel
10 papers
Ross Camidge
9 papers
Steven Feigenberg
9 papers
LR
Lauren Reed-Guy
8 papers · 1 as a resident

Clinical trials

Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy
Principal investigator · Recruiting · Phase 1, Phase 2
Abramson Cancer Center at Penn Medicine
2023–2027
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
Principal investigator · Recruiting · Phase 2
Abramson Cancer Center at Penn Medicine
2020–2026